Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Nevirapine
Teva Pharma GmbH
HIV-1
1 trial -
Norethindrone/Ethinyl Estradiol
Teva Pharma GmbH
Healthy
1 trial -
Norethindrone/Ethinyl Estradiol
Teva Pharma GmbH
Bioequivalence
1 trial -
Obatoclax mesylate (GX15-070MS)
Teva Pharma GmbH
Hematological Malignancies
1 trial -
Olanzapine Extended Release
Teva Pharma GmbH
Schizophrenia, Schizoaffective Disorder
1 trial -
Omacetaxine
Teva Pharma GmbH
Hematologic Tumors
1 trial -
Ondansetron
Teva Pharma GmbH
Healthy
2 trials -
Oxcarbazepine
Teva Pharma GmbH
Healthy
2 trials -
PROT-CL-NP101-015.01
Teva Pharma GmbH
Acute Migraine
1 trial -
Pantoprazole Sodium 40 mg delayed-release tablets
Teva Pharma GmbH
Healthy
2 trials -
Paroxetine HCl
Teva Pharma GmbH
Healthy
2 trials -
Pramipexole Dihydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Pravastatin sodium 80 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Progesterone vaginal ring,
Teva Pharma GmbH
Pharmacokinetics
1 trial -
Ramipril 10 mg capsule
Teva Pharma GmbH
Healthy
3 trials -
Reslizumab IV
Teva Pharma GmbH
Absolute Bioavailability
1 trial -
Ribavirin 200 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Risperidone
Teva Pharma GmbH
Healthy
2 trials -
Ropinirole HCl 0.25 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Rowasa® 4 gm/60 mL Rectal Enema
Teva Pharma GmbH
Healthy
1 trial -
SD-809
Teva Pharma GmbH
TOURETTE SYNDROME
1 trial -
Sublingual Tizanidine HCl
Teva Pharma GmbH
Traumatic Brain Injury
1 trial -
Sumatriptan succinate
Teva Pharma GmbH
Healthy
3 trials -
Sumatriptan succinate
Teva Pharma GmbH
Migraine Disorders
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources